GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

LUNG · Jun 30, 2024

Pulmonx Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001127537-24-000077General Corporate
Debt relative to revenueRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.debt_to_revenue

179.01% · OPTIONAL · NOT_ENOUGH_HISTORY

Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

2.26% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-27.76% · OPTIONAL · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

81.70% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_margin

73.65% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.operating_margin

-75.17% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

27.02% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

28.48% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History12 statesHistory building
Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/9 normalizedLevel 3Dec 31, 20240/9 normalizedLevel 3Mar 31, 20250/9 normalizedLevel 3Jun 30, 20250/9 normalizedLevel 3Sep 30, 20258/9 normalizedLevel 3Dec 31, 20258/9 normalizedLevel 3Mar 31, 20268/9 normalizedLevel 3Jun 30, 20268/9 normalizedLevel 3
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
197.48%
Current
179.01%
Delta
-18.47%
Capex Intensity Decreased
Previous
2.39%
Current
2.26%
Delta
-0.14%
Cash Generation Increased
Previous
-62.56%
Current
-27.76%
Delta
34.80%
Inventory Pressure Decreased
Previous
91.38%
Current
81.70%
Delta
-9.67%
Margin Decreased
Previous
74.67%
Current
73.65%
Delta
-1.02%
Profitability Increased
Previous
-77.10%
Current
-75.17%
Delta
1.93%
R And D Intensity Increased
Previous
22.33%
Current
27.02%
Delta
4.69%
Sbc Intensity Decreased
Previous
30.09%
Current
28.48%
Delta
-1.60%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · LUNG Fundamental State →Transitioned To · LUNG Fundamental State →Transitioned To · LUNG BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · LUNG CAPEX_INTENSITY_DECREASED →Transitioned To · LUNG CASH_GENERATION_INCREASED →Transitioned To · LUNG INVENTORY_PRESSURE_DECREASED →Transitioned To · LUNG MARGIN_DECREASED →Transitioned To · LUNG PROFITABILITY_INCREASED →Transitioned To · LUNG R_AND_D_INTENSITY_INCREASED →Transitioned To · LUNG SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.